Axsome Therapeutics (AXSM) Enterprise Value Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.40% |
| Dec 31, 2025 | -2.40% |
| Sep 30, 2025 | 0.61% |
| Jun 30, 2025 | 4.00% |
| Mar 31, 2025 | 9.21% |
| Dec 31, 2024 | 18.34% |
| Sep 30, 2024 | 21.44% |
| Jun 30, 2024 | 27.79% |
| Mar 31, 2024 | -34.46% |
| Dec 31, 2023 | -92.29% |
| Sep 30, 2023 | -83.10% |
| Jun 30, 2023 | -495.57% |
| Mar 31, 2023 | -191.03% |
| Dec 31, 2022 | -132.26% |
| Sep 30, 2022 | -98.53% |
| Jun 30, 2022 | 48.03% |
| Mar 31, 2022 | 48.56% |
| Dec 31, 2021 | 52.97% |
| Sep 30, 2021 | 43.37% |
| Jun 30, 2021 | 25.94% |
| Mar 31, 2021 | 16.55% |
| Dec 31, 2020 | 16.41% |
| Sep 30, 2020 | -363.68% |
| Jun 30, 2020 | -254.74% |
| Mar 31, 2020 | -362.91% |
| Dec 31, 2019 | -1,474.70% |
| Sep 30, 2019 | -186.73% |
| Jun 30, 2019 | -164.12% |
| Mar 31, 2019 | -60.05% |
| Dec 31, 2018 | 58.94% |
| Sep 30, 2018 | 51.94% |
| Jun 30, 2018 | 46.44% |
| Mar 31, 2018 | 40.84% |
| Dec 31, 2017 | 7.09% |
| Sep 30, 2017 | 6.53% |
| Jun 30, 2017 | 1.95% |
| Mar 31, 2017 | -2.14% |
| Dec 31, 2016 | 23.77% |
| Sep 30, 2016 | -633.36% |
| Jun 30, 2016 | -504.15% |
| Mar 31, 2016 | -2,507.50% |